arrow
L

Laura Falasca

department of epidemiology
H指数:32
被引数:3,962

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pulmonary Aspergillosis in Immunocompromised Critically Ill Patients: Prevalence, Risk Factors, Clinical Features and Diagnosis—A Narrative Review

免疫抑制危重患者中的肺曲霉病:患病率、危险因素、临床特征及诊断——一篇综述

2025-08-240
PRE
Antiviral Effects of Tecovirimat and Cellular Ultrastructural Changes in Human Bronchial Epithelial Cell Line Following Monkeypox Virus Infection

Tecovirimat的抗病毒效应及人支气管上皮细胞系在猴痘病毒感染后的细胞超微结构变化

2025-03-180
OA
Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications
2024-02-0110
OAAI
Utility of Liver Biopsy in the Diagnosis and Management of Possible Drug-Induced Liver Injury in Patients Receiving Antituberculosis Therapy: A Retrospective Study

肝活检在诊断和管理接受抗结核治疗患者可能的药物性肝损伤中的应用价值:一项回顾性研究

2023-11-280
OAAI
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma

2型转谷氨酰胺酶mitf轴调节皮肤皮肤黑素瘤的表型转换

2023-10-283
OAAI
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection

嘌呤能受体P2X7和NLRP3炎性体是SARS-CoV-2感染所需的可药物宿主因子

2023-10-187
OAAI
Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy

具有体外抗病毒活性和免疫调节作用的半胱胺有可能成为新型冠状病毒肺炎治疗的再利用候选药物

CELLS
IF5.2
2021-12-2415
OAAI